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Duration of the trial: 12 months, with monthly assessments, re- 
gardless of the day of application to each patient. 
Of the 20 patients, only 2 had a diagnosis of Chondromalasia, the 
others had Osteoarthritis G-II. 
Results: The assessment of the two treatment groups was eval- 
uated by the WOMAC scale in 4 categories: Poor, Fair, Good and 
Excellent. The difference for both treatment groups was statisti- 
cally significant (p=0.021). 
Pain in the evolution of the treated patients was evaluated using 
a scale of four categories: No Pain, Occasional Pain, Moderate 
Pain and Intense Pain. 40% of the patients in the HS/CS group 
had occasional, moderate or intense pain. While 90% of those 
who received Hylan GF-20 had occasional, moderate or intense 
pain. 
The evolution of the patients was evaluated by presence or ab- 
sence of crepitation in the treated joint. In this regard, the differ- 
ence between treatment groups was very significant (p=0.002), 
with presence of crepitation in 82% of the patients in the Hylan 
GF-20 group versus 18% of patients with crepitation in the HS/CS 
group. 
Any adverse event in each group. 
Conclusion: Definitely the evolution of the sintomatology and the 
function was better for the group treated with Sodium Hyaluronate 
and Chondroitin sulfate than for Hylan-GF 20. Although the begin- 
ning was similar for both in terms of controlling the pain, as the 
trial continued and time passed, the HS/CS group kept a stable 
improvement in this matter and in the function until the end of the 
trial. 
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Background: The benefits of arthroscopy for the treatment of os- 
teoarthritis of the knee have recently been questioned. Although 
joint replacement has successful results, many patients are seek- 
ing an alternative treatment to delay replacement. 
Type of Study: Case series 
Hypothesis/Purpose: The purpose of this study was to evalu- 
ate the functional and subjective outcomes of patients with se- 
vere osteoarthritis of the knee that underwent a comprehensive 
arthroscopic treatment regimen. 
Methods: Between August 2000 and November 2001, 69 
knees in 61 patients were treated with a comprehensive arthro- 
scopic regimen. Inclusion criteria included severe osteoarthritis 
(Kellgren-Lawrence score of 3 or 4) and minimum 2 year follow- 
up. Arthroscopic treatment included joint insufflation, lysis of ad- 
hesions, anterior interval release, contouring of cartilage defects 
and meniscus tears to a stable rim, synovectomy, removal of 
loose bodies, and removal of osteophytes that affected termi- 
nal extension. Exclusion criteria included treatment of chondral 
defects with microfracture. Failure of the arthroscopic protocol 
was defined as knees requiring arthroplasty. Preoperative radio- 
graphic analysis included joint space width, hip/knee angle, and 
shift in weight bearing axis measurements. The shift in the weight 
bearing axis was calculated as the ratio of the distance between 
the center of the knee joint to the point the axis intersected the 
knee and the width of the compartment through which the axis 
crossed. 
Results: The average patient age was 57 (range 37 to 78), with 
35 males and 26 females. Patients had an average of 1.5 previ- 
ous surgeries (range 0 to 12). The average pre-operative Lysholm 
score was 49 (range 14 to 79). On average, knees were insuf- 
flated with 170cc of lactated ringer's solution (range 120 to 240). 
Nine knees failed, with a survivorship of 83% at 3 years. Aver- 
age follow-up was 31 months (range 24 to 41). Average Lysholm 
was 74 (range 37 to 100), with an average improvement of 25 
points. The average Tegner was 4 (range 0 to 8). Average patient 
satisfaction was 8 (range 1 to 10). Average WOMAC pain was 
4 (range 0 to 14), WOMAC stiffness was 2 (range 0 to 4), and 
WOMAC function was 11 (range 0 to 44). Independent predictors 
of improvement in Lysholm score included shift in weight bearing 
axis and pre-operative Lysholm score. 
Conclusion: This comprehensive, arthroscopic treatment reg- 
imen can improve function and activity levels in patients with 
end stage osteoarthritis and, furthermore, can delay arthroplasty. 
Long term results are needed to determine how long arthroplasty 
can be delayed by treatment with this protocol. 
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Background: Osteoarthritis (OA) is the most prevalent ype of 
arthritis in the United States and is most common in the medial 
compartment of the knee. Many studies describe hallmark gait 
deviations in people with medial knee OA (MKOA) including re- 
duced knee flexion and greater knee adduction moments; how- 
ever, little emphasis has been placed on the associated muscle 
activation strategies used by these patients. Our previous work 
has shown that patients with MKOA use greater medial mus- 
cle co-activation during walking that may be a compensation for 
greater passive laxity that appears only on the medial side of 
the joint. Higher medial muscle co-contraction could exacerbate 
the progression of OA by further increasing contact forces in the 
diseased medial compartment. Recent work indicates that many 
people with MKOA report knee instability, described as the sen- 
sation of shifting, buckling or giving way in the knee. We hypothe- 
size that higher muscle co-activation may represent a strategy to 
reduce instability and that greater medial laxity may influence the 
instability thus eliciting more co-contraction among medial mus- 
cles. 
Aim of Study: The purpose of our study was to investigate the 
influences of self-reported knee instability on muscle activation 
strategies during a disturbed walking paradigm in which knee sta- 
bility is challenged. 
Methods: Five persons (39-72 yrs) with diagnosed MKOA (KL 
Grade II or greater) and five control subjects (38 - 71 yrs) with- 
out history of lower extremity problems participated. Sagittal and 
frontal plane joint angles and muscle activation data were col- 
lected simultaneously as each subject walked across a moveable 
platform for 20 walking trials. During 10 randomly distributed trials 
the platform translated laterally immediately following heel strike 
to challenge the stability of the joint. Muscle co-activation was de- 
termined for four muscle groups - lateral quadriceps/hamstrings 
(LQH), lateral quadriceps/gastrocnemius (LQG), medial quadri- 
ceps/hamstrings (MQH) and medial quadriceps/gastrocnemius 
(MQG). Self-reported knee instability (Knee Outcome Survey) 
was obtained from each subject. Analyses were performed and 
significance was set at p _<0.10. 
Results: Four of the five subjects with MKOA reported knee in- 
stability; 3 subjects reported that instability interferes with daily 
function. No control subjects reported instability. When stability 
was challenged, subjects with MKOA (OA) demonstrate greater 
knee flexion during midstance (p=0.016) and greater muscle co- 
contraction during the initial loading phase of gait as well as dur- 
ing midstance (p=0.019 - 0.10). 
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Conclusions: Our preliminary results confirm that self-reported 
knee instability was experienced by most of the subjects with 
MKOA and that individuals with MKOA use higher muscle co- 
contraction in muscles surrounding the knee in response to a 
destabilizing event. With a larger sample size we hope to de- 
termine the influence of self-reported knee instability, as well as 
quadriceps femoris strength, on the muscle activation strategies 
in people with MKOA. 
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Study Aim: To test the hypothesis that knee joint intervention 
with papain, saline and empty needle injections alter quadriceps 
muscle function as assessed by 3~ p nuclear magnetic resonance 
spectroscopy (NMRS) and measurement of contractile force. 
Methods:  Adult female F344 rats were injected with 20mL of ei- 
ther papain solution (PAP: n= 7) or saline (SAL: n= 9) oran empty 
syringe (IN J: n=9) on days 1,4 and 7 were compared with control 
animals (CTL: n=6). Quadriceps muscle NMRS was performed 
on day 15 with a 1.9 T, 31 cm Bruker ABX Biospec. The muscle 
was directly stimulated using a pair of rectangular pulses each of 
duration 5 ms, with an interval between the pulses of 200 ms and 
an interval between the pulse pairs of 2 s. Spectra were recorded 
with an interpulse delay of 1 s and flip angle of 90 ° for 1 minute. 
A total of 25 spectra were acquired at baseline (2), during elec- 
trical stimulation (8) and recovery to baseline (15). The ratio of 
phosphocreatine to the sum of phosphocreatine and inorganic 
phosphate [PCr/(PCr+Pi)], muscle oxidative capacity (Vm) and 
pH were obtained from the 3~ p data. Contractile force was mea- 
sured with a force transducer and is expressed relative to initial 
force. H & E stained joint sections were scored for severity of 
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cartilage degradation. Two-way repeated-measures ANOVA was 
used to compare the metabolite ratios and relative force during 
stimulation and early recovery periods between groups. ANOVA 
was used for all other analyses. Statistical significance was as- 
sessed at P<0.05. Data are shown as mean 4- SEM. 
Results: As shown in Figure A, the PCr/(PCr+Pi) ratio decreased 
more rapidly with more rapid fatigue during electrical stimulation 
and remained lower during early recovery in IN J, SAL and PAP 
groups compared to CTL (p<0.05). Quadriceps muscles also 
exhibited more rapid fatigue in all treatment groups than CTLs 
(p<0.05) (Figure B). At 8-minutes of stimulation, pH was signif- 
icantly lower in all of the intervention groups compared to CTL, 
while relative oxidative capacity was significantly lower in PAP 
and SAL groups than INJ and CTL (p<0.05). Significant cartilage 
degradation was observed in the PAP but not in either SAL or INJ 
specimens. 
Conclusions: These results suggest that knee joint injection de- 
pletes quadriceps muscle metabolic reserve and causes acceler- 
ated fatigue observable with sustained electrical stimulation with- 
out significant differences in magnitude or time course between 
intervention groups. These changes were induced independent 
of cartilage degradation. 
This work was completely supported by the National Institute on 
Aging Intramural Research Program. 
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WOMEN WITH HAND OSTEOARTHRITIS (OA) SHOW 
HIGHER LEVELS OF PAIN, HIGHER SCORES OF 
FIBROMYALGIA-LIKE SYMPTOMS AND MORE MENTAL 
DISTRESS COMPARED TO WOMEN WITH RHEUMATOID 
ARTHRITIS (RA) 
B Slatkowsky-Christensen, P Mowinckel, TK Kvien 
Rheumatology, Diakonhjemmet Hospital, Oslo, Norway 
Aim of Study: Different dimensions of health related quality of life 
(HRQoL) as pain and other disease related symptoms represent 
major problems for patients with OA as well as for patients with 
RA. The aim of this study was to compare self reported health 
status and perception of fibromyalgia-like symptoms between fe- 
male OA and RA patients. 
Methods:  One hundred and ninety patients with hand OA and 
194 with RA between 50 and 70 years of age, referred to our 
rheumatology department within the preceding two years, un- 
derwent a comprehensive clinical examination including comple- 
tion of several self-reported health status questionnaires. Among 
these were AIMS2, SF-36 (also used to compute the utility mea- 
sure SF-6D), MHAQ, HAQ, pain, fatigue, patient global on vi- 
sual analogue scales (VAS) and self-efficacy scales. Also in- 
corporated were VAS to score headache, muscular tenderness, 
numbness of the fingers and concentration problems. All patients 
completed identical questionnaires. We present crude values, 
since similar scores were found after adjustment for potential con- 
Mean (SD) scores of selected health status measures in hand OA and RA 
OA (SD) RA (SD) p-value 
(n=190) (n=194) 
Pain scales 
AIMS2 5.63 (2.3) 4.78 (2.5) 0.001 
SF-36 39.6 (23.4) 44.1 (24.0) 0.03 
VAS 39.5 (22.6) 36.4 (23.4) 0.18 
Mental scales 
AIMS2 affect 3.65 (1.7) 3.17 (1.7) 0.008 
SF-36 68.2 (20.3) 73.3 (19.1) 0.01 
Fibromyalgia like symptoms (VAS) 
Muscle pain 45.2 (29.3) 36.3 (26.9) 0.003 
Concentration problems 23.1 (25.4) 17.5 (18.7) 0.02 
Numbness 28.9 (28.4) 16.0 (22.1) 0.001 
